Glenn Rall1, Laura J Knoll2. 1. Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America. 2. Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
There is an inherent catch-22 in performing research that aims to better understand a
clinical disease: to make true strides, one needs to simplify the system sufficiently to
test individual variables. However, reducing a complex process to an experimentally
approachable, simplified system may be so reductionist that the results are irrelevant
to the disease in question. For many of us, animal models have proven to be remarkably
powerful. Indeed, many biological principles were uncovered and major clinical advances
made using animal models, and the advent of transgenic, knockout, and conditional
animals has further cemented their value to the pathogenesis field. While animal models
of infection have been invaluable, the simplified nature of most models has prevented a
complete understanding of the more complex ways by which pathogens can cause human
disease. For example, much of what we know about infectious agent pathogenesis has been
gained from the use of adult, immunocompetent, immunologically naïve, inbred mice
infected with a single pathogen. In stark contrast, humans with vastly different
immunological histories and genetic backgrounds are colonized by a diverse array of
microbial communities and likely bombarded with temporally overlapping antigenic
stimuli. Despite this discrepancy between mouse models and the human experience, we know
very little about how concurrent immune responses interact and contribute to disease in
either humans or mice. This gap in knowledge is important to remedy because many human
diseases are caused by polymicrobial exposures—including pneumonia, peritonitis, and
others (e.g., hepatitis and Lyme’s disease [1,2])—that can have exacerbated symptoms when combined with a second pathogen.
Moreover, any immunogen, even those that are noninfectious, may be relevant in this
context, including allergens and vaccinations or preexisting chronic conditions such as
cancer or autoimmunity. Many who have begun to explore this area in more depth have
contended that temporally overlapping infections or immune responses may play a
foundational role in some poorly understood inflammatory illnesses in humans.If models are to be useful to fully explore this hypothesis, then more complex systems
must be developed. Guiding the development of such systems should be fundamental
questions such as: Is the immune response to a given immune stimulus functionally
identical, regardless of whether the host is challenged with other, distinct immunogens?
How might the response to one challenge influence the induction or trafficking of
lymphocytes to a different challenge, especially if the two immunogens are
tissue-restricted? Most critically: how might temporally overlapping infections alter
pathogenesis? That is, could novel diseases occur only following simultaneous
immunogenic encounters? One can envision that coincident infections could change a
pathogenic outcome either directly or indirectly. Direct pathogen–pathogen interactions
can exacerbate disease, as seen in otitis media, pneumonia, and sinusitis [1,3]. Alternatively, activated immune responses may
interact in various ways to provoke illness. These include: (i) immunological
interference, in which concurrent Th1 and Th2 immune responses limit efficient pathogen
clearance [4-6]; (ii) cross-reactive responses,
in which epitopes from otherwise diverse pathogens may be recognized by the same T cell
receptors [7,8]; and (iii) persistent
infections, such as those caused by some viruses, bacteria, or parasites, which confer
protection to a subsequent acute challenge by resetting the homeostatic immunological
“setpoint.”To incentivize more thinking in this emerging scientific area, we have selected research
articles from the PLOS Pathogens archive that directly tackle some of
these issues. Of the over 70 excellent articles that the journal has published to date,
we have chosen a select few from a diversity of systems that we believe are of
particular interest to feature in the new PLOS Pathogens collection,
“Bridging Communities: Co- and Polymicrobial Infections.” These articles
have made substantive mechanistic advances to reveal how overlapping infections, or the
immune responses they stimulate, might interact in novel ways. With this subset, we have
also endeavored to underscore some of the unique approaches used by investigators in the
various pathogenic disciplines PLOS Pathogens supports. Many more
published articles that cover this area are available in the Supporting Information
(S1
Table).More than just a historical appreciation, we hope that this collection will promote
deeper discussions and increased research article submissions focused on polymicrobial
infections, especially by trainees who are considering what fields to pursue as
independent investigators. In addition to the importance of the science that is done,
research on polymicrobial infections and disease will bridge scientific communities,
break down walls that preclude truly free exchanges of ideas and reagents, and expedite
discovery of new principles. We anxiously look forward to the surprising and important
insights such efforts will yield.
Additional PLOS Pathogens co- and polymicrobial
published articles.
Authors: A Farid; M Al-Sherbiny; A Osman; N Mohamed; A Saad; M T Shata; D-H Lee; A M Prince; G T Strickland Journal: Parasite Immunol Date: 2005-05 Impact factor: 2.280
Authors: Chelsie E Armbruster; Sara N Smith; Alexandra O Johnson; Valerie DeOrnellas; Kathryn A Eaton; Alejandra Yep; Lona Mody; Weisheng Wu; Harry L T Mobley Journal: Infect Immun Date: 2017-01-26 Impact factor: 3.441
Authors: Anna Manko; Jean-Paul Motta; James A Cotton; Troy Feener; Ayodele Oyeyemi; Bruce A Vallance; John L Wallace; Andre G Buret Journal: PLoS One Date: 2017-06-16 Impact factor: 3.240
Authors: Juan de Dios Caballero; Rafael Cantón; Manuel Ponce-Alonso; Marta María García-Clemente; Elia Gómez G de la Pedrosa; José Luis López-Campos; Luis Máiz; Rosa Del Campo; Miguel Ángel Martínez-García Journal: Microorganisms Date: 2022-04-13